Oct 25 Stanford’s StartX Selects Deep 6 Analytics for Accelerator Program
Deep 6 Analytics, an artificial intelligence-enabled technology platform for matching patients to clinical trials, is extremely excited to have been accepted into Stanford’s StartX Accelerator Fall 2016 Program. StartX is an industry- and stage-agnostic nonprofit organization that helps the highest potential entrepreneurs in the Stanford University network succeed by providing tactical help, experiential education, funding, and a vast network of mentors and investors. The highly-competitive program has historically accepted 8 to 10 percent of applicants.
StartX founders tackle big problems in every industry, from biotech, medical device, hardware, cleantech, and non-profit to consumer and enterprise IT. The StartX community will provide Deep 6 Analytics with access to 800+ alumni founders, world-class coaches and advisors, angel investors and venture capitalists, and customized educational programming based on team, industry and stage. In addition, Deep 6 Analytics will receive resources worth more than $600,000 from StartX program partners. The organization takes zero equity.
StartX gives us access to an extremely talented and diverse community and set of mentors whose advice and assistance can move us forward in a way not possible on our own.
StartX represents another addition to the Deep 6 Analytics’ growing list of accomplishments, which includes acceptance into the Techstars Healthcare Accelerator in partnership with Cedars-Sinai and Healthbox’s modified-accelerator program. Deep 6 Analytics has also won US government-sponsored contests, beating out some of the biggest names in analytics.
StartX is a 501(c)(3) Stanford-affiliated nonprofit in Silicon Valley that runs one of the world’s top startup accelerator programs. Our mission is to advance the development of the best entrepreneurs through experiential education and peer learning. Since launching in 2010, we have supported more than 400 companies and 800 entrepreneurs, from early to pre-IPO stage, working across a wide spectrum of industries. StartX and StartX Med, dedicated to medical and biotechnology innovation, provide founders with access to a powerful network of entrepreneurs, investors, mentors, and industry partners, along with office space and a variety of other resources. Based in Palo Alto, the accelerator also operates StartX-QB3 Labs and the Stanford-StartX Fund.